Accustem Sciences Inc. Contracts & Agreements

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 15, 2023)

Form of Underwriting Agreement (Filed With SEC on November 17, 2022)

Form of common stock certificate (Filed With SEC on November 17, 2022)

Shared Services Agreement by and between Accustem Sciences Ltd. and Tiziana Life Sciences plc dated as of January 1, 2021 (Filed With SEC on November 17, 2022)

Offer Letter dated February 18, 2022 between Accustem Sciences, Inc. and Wendy Blosser (Filed With SEC on November 17, 2022)

Offer Letter dated November 25, 2021 between Accustem Sciences, Inc. and Jeff Fensterer (Filed With SEC on November 17, 2022)

Offer Letter dated December 6, 2021 between Accustem Sciences, Inc. and Joe Flanagan (Filed With SEC on November 17, 2022)

Consulting Agreement dated March 21, 2021 between Keeren Shah and Accustem Sciences, Inc (Filed With SEC on November 17, 2022)

Consulting Agreement dated January 1, 2022 between Gabriele Cerrone and Accustem Sciences, Inc (Filed With SEC on November 17, 2022)

First Amendment to License Agreement by and between AccuStem Sciences, Inc., Istituto Europeo di Oncologia Srl and Universita degli Studi di Milano, dated November 9, 2022 (Filed With SEC on November 17, 2022)

Amendment to Consulting Agreement dated July 22, 2021 between Keeren Shah and Accustem Sciences, Inc (Filed With SEC on November 17, 2022)

Form of Common Stock Purchase Agreement (Filed With SEC on April 5, 2022)

Offer Letter dated February 18, 2022 between AccuStem Sciences, Inc. and Wendy Blosser (Filed With SEC on March 10, 2022)

Form of New Option (Filed With SEC on December 3, 2021)

Form of Indemnification Agreement (Filed With SEC on December 3, 2021)

Accustem Sciences Inc. 2021 Equity Incentive Plan (Filed With SEC on December 3, 2021)

Category

Industry

Companies

Contracts

Accustem Sciences Inc. Contracts & Agreements